ICM
BMY icon

Islay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Islay Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-823
Closed -$53K – 260
2019
Q4 		$53K Buy
+823
New +$47.1K 0.05% 164

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Islay Capital Management's BMY Position: Q1 2020 in Review

Islay Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 823 shares — an estimated $53K sold.

Islay Capital Management first reported a position in BMY in Q4 2019 and held it in 1 quarter. The position peaked at $53K in Q4 2019. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Islay Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Islay Capital Management sold 823 Bristol-Myers Squibb shares in Q1 2020, an estimated $53K.
  • Islay Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 1 quarter.
  • Islay Capital Management's Bristol-Myers Squibb position peaked at $53K in Q4 2019.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Islay Capital Management's 13F filing for Q1 2020, filed 6 May 2020.